Humana Inc.
400.02USD
-3.0700 (-0.76%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.94▼ | $-0.15 | 5 | 16 |
| Next quarter | $-7.92▲ | $-8.07 | 16 | 5 |
| Current year | $9.15▲ | $8.84 | 12 | 3 |
| Next year | $16.57▲ | $15.71 | 16 | 3 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $7 | $7.61 | +0.61 (+8.8%) |
| 2026-03-31 | $10.2 | $10.31 | +0.11 (+1.1%) |
| 2025-12-31 | $-3.99 | $-3.96 | +0.03 (+0.7%) |
| 2025-09-30 | $2.83 | $3.24 | +0.41 (+14.6%) |
428 ratings from 42 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Neutral | $316 $393 | Aug 10, 2026 |
| Morgan Stanley | Upgraded from Underweight | Equal-Weight | $249 $370 | Aug 5, 2026 |
| TD Cowen | Maintained | Hold | $350 $370 | Jul 31, 2026 |
| Barclays | Maintained | Equal-Weight | $344 $407 | Jul 31, 2026 |
| UBS | Maintained | Neutral | $320 $405 | Jul 30, 2026 |
| Evercore ISI Group | Upgraded from In-Line | Outperform | $430 $480 | Jul 30, 2026 |
| Guggenheim | Maintained | Buy | $269 $471 | Jul 30, 2026 |
| Raymond James | Downgraded from Outperform | Market Perform | — | Jul 30, 2026 |
| TD Cowen | Maintained | Hold | $211 $350 | Jul 14, 2026 |
| Truist Securities | Maintained | Hold | $320 $415 | Jul 14, 2026 |
| Wells Fargo | Upgraded from Equal-Weight | Overweight | $227 $502 | Jul 13, 2026 |
| RBC Capital | Maintained | Sector Perform | $246 $415 | Jul 9, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $264 $300 | Jul 7, 2026 |
| B of A Securities | Maintained | Neutral | $340 $380 | Jun 24, 2026 |
| Evercore ISI Group | Maintained | In-Line | $250 $370 | Jun 11, 2026 |
| Mizuho | Maintained | Outperform | $335 $390 | Jun 8, 2026 |
| JP Morgan | Maintained | Neutral | $214 $316 | Jun 8, 2026 |
| B of A Securities | Maintained | Neutral | $267 $340 | Jun 4, 2026 |
| Morgan Stanley | Maintained | Underweight | $217 $249 | Jun 4, 2026 |
| Truist Securities | Maintained | Hold | $270 $320 | Jun 1, 2026 |
| Barclays | Maintained | Equal-Weight | $180 $344 | May 26, 2026 |
| UBS | Maintained | Neutral | $262 $320 | May 22, 2026 |
| Mizuho | Maintained | Outperform | $290 $335 | May 20, 2026 |
| Deutsche Bank | Upgraded from Hold | Buy | $235 $441 | May 20, 2026 |
| Morgan Stanley | Maintained | Underweight | $146 $217 | May 15, 2026 |
70 filings from 23 insiders · 0 buy / 0 sell over 6m
Officers and directors of HUM, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Nundy ShantanuOfficer, Chief Medical Officer | Grant | 2.5k | — | — | Sep 1, 2026 |
| SMITH PAUL JOHNDirector | Grant | 544 | — | — | Jul 31, 2026 |
| CRAWFORD FREDERICK JOHNDirector | Grant | 544 | — | — | Jul 31, 2026 |
| DINTENFASS DAVIDOfficer | Grant | 11.3k | — | — | May 1, 2026 |
| MEHTA JAPANChief Technology Officer | Grant | 9.4k | — | — | May 1, 2026 |
| MELLET CELESTEChief Financial Officer | Grant | 15.4k | — | — | May 1, 2026 |
| MARTIN AARONOfficer | Grant | 8.2k | — | — | May 1, 2026 |
| FIELD ROBERT STUARTDirector | Grant | 852 | — | — | May 1, 2026 |
| VENTURA JOSEPH CHRISTOPHEROfficer | Grant | 10.3k | — | — | May 1, 2026 |
| O'HARA MICHELLE A.Officer | Grant | 10.5k | — | — | May 1, 2026 |
| SHETTY SANJAY KOfficer | Grant | 9.9k | — | — | May 1, 2026 |
| RECHTIN JAMES A.Chief Executive Officer | Grantindirect | 35.6k | — | — | May 1, 2026 |
| SHETTY SANJAY KOfficer | Other | 887 | — | — | Apr 1, 2026 |
| VENTURA JOSEPH CHRISTOPHEROfficer | Other | 1.0k | — | — | Feb 24, 2026 |
| FELTER JOHN- PAUL W.Officer | Other | 165 | — | — | Feb 24, 2026 |
| RENAUDIN GEORGE IIOfficer | Other | 1.0k | — | — | Feb 24, 2026 |
| SHETTY SANJAY KOfficer | Buy | 810 | $185.20 | $150k | Feb 23, 2026 |
| FELTER JOHN- PAUL W.Officer | Grant | 5.7k | — | — | Feb 23, 2026 |
| DINTENFASS DAVIDOfficer | Other | 3.9k | — | — | Feb 20, 2026 |
| MEHTA JAPANChief Technology Officer | Other | 1.7k | — | — | Feb 13, 2026 |
No analyst notes on HUM yet.
Analyst Ratings
23 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 11 | 13 | 1 | 0 | Hold2.54 |
| 1 mo ago | 1 | 11 | 13 | 1 | 0 | Hold2.54 |
| 2 mo ago | 1 | 11 | 12 | 2 | 0 | Hold2.58 |
| 3 mo ago | 1 | 7 | 16 | 2 | 0 | Hold2.73 |